BioCryst Pharmaceuticals
BCRX
#4439
Rank
C$3.75 B
Marketcap
C$14.69
Share price
7.11%
Change (1 day)
30.07%
Change (1 year)

Market capitalization of BioCryst Pharmaceuticals (BCRX)

Market cap: C$3.75 Billion

As of August 2026 BioCryst Pharmaceuticals has a market cap of C$3.75 Billion. This makes BioCryst Pharmaceuticals the world's 4439th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of BioCryst Pharmaceuticals from 1996 to 2026

End of year Market Cap

Year Marketcap Change
2026C$3.75 B70.48%
2025C$2.20 B-3.91%
2024C$2.29 B40.84%
2023C$1.62 B-43.97%
2022C$2.90 B-8.56%
2021C$3.17 B89.36%
2020C$1.67 B141.58%
2019C$0.69 B-42.62%
2018C$1.20 B99.18%
2017C$0.60 B-3.18%
2016C$0.62 B-40.25%
2015C$1.05 B3.42%
2014C$1.01 B112.39%
2013C$0.47 B565.24%
2012C$71.86 M-36.74%
2011C$0.11 B-51.11%
2010C$0.23 B-22.15%
2009C$0.29 B368.3%
2008C$63.72 M-72.77%
2007C$0.23 B-40.54%
2006C$0.39 B-29.94%
2005C$0.56 B271.99%
2004C$0.15 B-4.88%
2003C$0.15 B493.16%
2002C$26.77 M-75.9%
2001C$0.11 B-36.19%
2000C$0.17 B-76.3%
1999C$0.73 B356.22%
1998C$0.16 B16.5%
1997C$0.13 B-55.02%
1996C$0.30 B

End of Day market cap according to different sources

On Aug 10th, 2026 the market cap of BioCryst Pharmaceuticals was reported to be:

C$3.50 Billion
by Nasdaq info icon info icon
C$3.50 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Gilead Sciences
GILD
C$234.38 B 6,143.77%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
C$142.78 B 3,703.59%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
C$2.64 B-29.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
C$13.10 B 249.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
C$1.79 B-52.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
C$4.86 B 29.66%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
C$48.38 M-98.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
C$36.9 M-99.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
C$0.31 B-91.53%๐Ÿ‡บ๐Ÿ‡ธ USA